ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,482Medicare Part D Prescriptions Filled, Including Refills

Rank: 124 out of 617

$559K Total Retail Price of All Prescriptions

Rank: 65 out of 617

363 Patients Receiving at Least One Drug in Part D
73%Patients 65 Years and Older
37% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Nebraska
Lower avg

Schedule Two
Controlled Substances

8% of this provider’s 363 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

22% of this provider’s 363 patients filled at least one prescription for a schedule three drug, compared to an average of 11%.

Risky Drugs to Seniors

1% of this provider’s 7,281 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

27% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$59 was the average price of a prescription from this provider, compared to $49 among peers.

Prescriptions per Patient

26 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Nebraska
SIMVASTATIN 481 386 1 2
OMEPRAZOLE 382 302 2 3
LEVOTHYROXINE SODIUM 362 263 3 1
HYDROCODONE-ACETAMINOPHEN 321 136 S3 4 8
AMLODIPINE BESYLATE 260 217 5 6
PRAVASTATIN SODIUM 258 231 6 21
CRESTOR 253 157 7 28
METFORMIN HCL 217 142 8 9
WARFARIN SODIUM 205 196 9 7
HYDROCHLOROTHIAZIDE 203 188 10 13
ZETIA 179 159 11 77
ALENDRONATE SODIUM 178 172 12 25
LISINOPRIL 163 121 13 5
ATORVASTATIN CALCIUM 163 118 13 14
SERTRALINE HCL 144 135 15 20
GABAPENTIN 127 109 16 16
ZOLPIDEM TARTRATE 120 101 17 23
DOXYCYCLINE HYCLATE 119 90 18 113
NABUMETONE 119 70 18 120
FUROSEMIDE 114 91 20 4
METOPROLOL TARTRATE 108 99 21 11
TRICOR 107 63 22 83
CLONIDINE HCL 107 94 22 55
POTASSIUM CHLORIDE 99 83 24 10
TAMSULOSIN HCL 99 91 24 26
ACTOS 95 80 26 85
LOVASTATIN 94 91 27 57
NIASPAN 90 42 28 103
ATENOLOL 86 82 29 17
METOPROLOL SUCCINATE 79 65 30 12
CARVEDILOL 76 72 31 19
CYCLOBENZAPRINE HCL 76 33 R 31 74
TRAMADOL HCL 76 50 31 15
PREDNISONE 75 56 34 31
CELEBREX 67 53 35 63
LISINOPRIL-HYDROCHLOROTHIAZIDE 66 46 36 29
BYSTOLIC 60 45 37 64
JANUVIA 57 53 38 107
CITALOPRAM HBR 57 37 38 18
ADVAIR DISKUS 56 28 40 38
NEXIUM 56 49 40 43
TRIAMTERENE-HCTZ 55 55 42 47
PRADAXA 55 35 42 254
PIOGLITAZONE HCL 54 45 R 44 239
OXYBUTYNIN CHLORIDE 54 48 44 88
METHYLPREDNISOLONE 54 36 44 208
FENOFIBRATE 52 28 47 58
PROPRANOLOL HCL 50 50 48 109
OXYCODONE HCL-ACETAMINOPHEN 50 37 S2 48 134
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Sept. 25, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.